Skip to main content
. 2017 Sep 30;47(3):173–179. doi: 10.28920/dhm47.3.173-179

Figure 2.

Figure 2

Numbers of respondents by gender reporting regular medications; AntiHT – hypertension medication; LLA – lipid lowering agent; OAD – oral anti-diabetics; OCP – oral contraceptive pills (not all respondents answered the questions)